CRDF - Cardiff Oncology - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

CRDF is currently covered by 3 analysts with an average price target of $16.11. This is a potential upside of $10.36 (180.17%) from yesterday's end of day stock price of $5.75.

Cardiff Oncology's activity chart (see below) currently has 7 price targets and 19 ratings on display. The stock rating distribution of CRDF is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 8.33% with an average time for these price targets to be met of 133.25 days.

Highest price target for CRDF is $7, Lowest price target is $7, average price target is $16.11.

Most recent stock forecast was given by JOSEPH CATANZARO from PIPER SANDLER on 01-Mar-2024. First documented stock forecast 08-Oct-2020.

Best performing analysts who are covering CRDF - Cardiff Oncology:

Joseph Catanzaro Raghuram Selvaraju Joel Beatty Naureen Quibria

Currently out of the existing stock ratings of CRDF, 10 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

7

$1.25 (21.74%)

28 days ago

0/4 (0%)

$4.09 (140.55%)

Buy

5

$-0.75 (-13.04%)

6

1 years 6 months 2 days ago

1/3 (33.33%)

$3.45 (222.58%)

533

Buy

25

$23.61 (1698.56%)

2 years 6 months 20 days ago

0/1 (0%)

$18.01 (257.65%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRDF (Cardiff Oncology) average time for price targets to be met?

On average it took 133.25 days on average for the stock forecasts to be realized with a an average price target met ratio 8.33

Which analyst has the current highest performing score on CRDF (Cardiff Oncology) with a proven track record?

JOSEPH CATANZARO

Which analyst has the current lower performing score on CRDF (Cardiff Oncology) with a proven track record?

NAUREEN QUIBRIA

Which analyst has the most public recommendations on CRDF (Cardiff Oncology)?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 7 ratings on CRDF

Which analyst is the currently most bullish on CRDF (Cardiff Oncology)?

Naureen Quibria with highest potential upside - $23.61

Which analyst is the currently most reserved on CRDF (Cardiff Oncology)?

Joel Beatty with lowest potential downside - -$0.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?